Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Dan

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Diabetes Research and Clinical Practice|October 29, 2008
Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine for the treatment of diabetic nephropathy?Toshio Miyata, Takashi Dan
Skeletal Muscle|March 8, 2016
Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathwayJunchul Shin, Aki Nunomiya, Yasuo Kitajima, et al.
The Tohoku Journal of Experimental Medicine|March 10, 2015
Hypoxia-sensitive reporter system for high-throughput screeningTadayuki Tsujita, Shin-ichi Kawaguchi, Takashi Dan, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2018
Identification of novel plasminogen activator inhibitor-1 inhibitors with improved oral bioavailability: Structure optimization of N-acylanthranilic acid derivativesNagahisa Yamaoka, Kenji Murano, Hidehiko Kodama, et al.
Thrombosis Research|April 25, 2013
TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cellsHideki Yasui, Yuko Suzuki, Hideto Sano, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 19, 2009
A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damageShunya Takizawa, Takashi Dan, Tsuyoshi Uesugi, et al.
Journal of Obesity|August 12, 2010
Body weight control by a high-carbohydrate/low-fat diet slows the progression of diabetic kidney damage in an obese, hypertensive, type 2 diabetic rat modelShuichi Ohtomo, Yuko Izuhara, Masaomi Nangaku, et al.
Plos One|April 28, 2015
Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple SclerosisNicolas Pelisch, Takashi Dan, Atsuhiko Ichimura, et al.
Cancer Medicine|September 24, 2022
Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor-1 inhibitor TM5614 combined with a tyrosine kinase inhibitorNaoto Takahashi, Yoshihiro Kameoka, Makoto Onizuka, et al.
Stem Cells (Dayton, Ohio)|October 25, 2013
Inhibition of plasminogen activator inhibitor type-1 activity enhances rapid and sustainable hematopoietic regenerationAbd Aziz Ibrahim, Takashi Yahata, Makoto Onizuka, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Diabetes Research and Clinical Practice|October 29, 2008
Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine for the treatment of diabetic nephropathy?Toshio Miyata, Takashi Dan
Skeletal Muscle|March 8, 2016
Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathwayJunchul Shin, Aki Nunomiya, Yasuo Kitajima, et al.
The Tohoku Journal of Experimental Medicine|March 10, 2015
Hypoxia-sensitive reporter system for high-throughput screeningTadayuki Tsujita, Shin-ichi Kawaguchi, Takashi Dan, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2018
Identification of novel plasminogen activator inhibitor-1 inhibitors with improved oral bioavailability: Structure optimization of N-acylanthranilic acid derivativesNagahisa Yamaoka, Kenji Murano, Hidehiko Kodama, et al.
Thrombosis Research|April 25, 2013
TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cellsHideki Yasui, Yuko Suzuki, Hideto Sano, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 19, 2009
A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damageShunya Takizawa, Takashi Dan, Tsuyoshi Uesugi, et al.
Journal of Obesity|August 12, 2010
Body weight control by a high-carbohydrate/low-fat diet slows the progression of diabetic kidney damage in an obese, hypertensive, type 2 diabetic rat modelShuichi Ohtomo, Yuko Izuhara, Masaomi Nangaku, et al.
Plos One|April 28, 2015
Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple SclerosisNicolas Pelisch, Takashi Dan, Atsuhiko Ichimura, et al.
Cancer Medicine|September 24, 2022
Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor-1 inhibitor TM5614 combined with a tyrosine kinase inhibitorNaoto Takahashi, Yoshihiro Kameoka, Makoto Onizuka, et al.
Stem Cells (Dayton, Ohio)|October 25, 2013
Inhibition of plasminogen activator inhibitor type-1 activity enhances rapid and sustainable hematopoietic regenerationAbd Aziz Ibrahim, Takashi Yahata, Makoto Onizuka, et al.
Pageof 3